HEXO Corp. (HEXO) |
|
1.3 0.05 (4%)
|
03-24 16:00 |
|
Open: |
1.25 |
Pre. Close: |
1.25 |
|
High:
|
1.3 |
Low:
|
1.22 |
|
Volume:
|
192,053 |
Market Cap:
|
57(M) |
|
|
|
Technical analysis |
as of: 2023-03-24 4:26:41 PM |
|
Overall:
|
  |
| Stoxline posted a BUY today, upgraded from lower rating. Upward movement to be expected. |
| Target: |
Six months: 1.86 One year: 2.16 |
| Support: |
Support1: 1.17 Support2: 0.98 |
| Resistance: |
Resistance1: 1.59 Resistance2: 1.85 |
| Pivot: |
1.39  |
| Moving Average: |
MA(5): 1.26 MA(20): 1.46
MA(100): 1.75 MA(250): 2.85 |
| MACD: |
MACD(12,26): -0.1 Signal(9): -0.1 |
| Stochastic oscillator: |
%K(14,3): 17.7 %D(3): 16.4 |
| RSI: |
RSI(14): 40.6 |
| 52-week: |
High: 9.04 Low: 0.19 |
| Average Vol(K): |
3-Month: 1,155 (K) 10-Days: 416 (K) |
|
Price, moving averages and Bollinger Bands |
|
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.[ HEXO ] has closed above bottom band by 29.5%. Bollinger Bands are 24.9% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices. |
|
|
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
1.3 - 1.31 |
1.31 - 1.31 |
|
Low:
|
1.21 - 1.21 |
1.21 - 1.22 |
|
Close:
|
1.29 - 1.3 |
1.3 - 1.31 |
|
Company Description |
|
HEXO Corp., through its subsidiaries, produces, markets, and sells cannabis in Canada. The company offers its adult-use and medical products under the HEXO brand name. It also provides cannabis beverages under the Little Victory, House of Terpenes, Mollo, Veryvell, and XMG brands; and cannabis products under UP Cannabis, Original Stash, and Up brand names. HEXO Corp. has a strategic alliance with Tilray Brands, Inc. The company was formerly known as The Hydropothecary Corporation and changed its name to HEXO Corp. in August 2018. HEXO Corp. was founded in 2013 and is headquartered in Gatineau, Canada. |
Headline News |
Fri, 24 Mar 2023
HEXO Ranks on The Globe and Mail's Fourth-Annual Women Lead ... - Business Wire
Tue, 21 Mar 2023
What does HEXO's (TSX:HEXO) recent performance say about the ... - Stockhouse
Sun, 19 Mar 2023
HEXO Corp. (NASDAQ:HEXO) Q2 2023 Earnings Call Transcript - Yahoo Finance
Fri, 17 Mar 2023
Cannabis 'price war' could cause 'significant' damage to industry ... - The Globe and Mail
Fri, 17 Mar 2023
HEXO Corp (HEXO) Q2 2023 Earnings Call Transcript - AlphaStreet
Thu, 16 Mar 2023
HEXO: Financial Standing Raises Doubt About Ability to Meet Obligations - MarketWatch
|
Financial Analysis |
| Price to Book Value: |
Neutral |
| P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
| Price to Earnings: |
Outperform |
| PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
| Discounted cash flow: |
Outperform |
| DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
| Return on Assets: |
Neutral |
| ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
| Return on Equity: |
Neutral |
| ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
| Debt to Equity: |
Outperform |
| evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: NASDAQ |
| Sector: Healthcare |
| Industry: Drug Manufacturers—Specialty & Generic |
| Shares Out. |
43 (M) |
| Shares Float |
37 (M) |
|
% Held by Insiders
|
3 (%) |
|
% Held by Institutions
|
8.4 (%) |
|
Shares Short
|
1,780 (K) |
|
Shares Short P.Month
|
2,240 (K) |
Stock Financials |
|
EPS
|
-20.86 |
|
EPS Est Next Qtl
|
0 |
|
EPS Est This Year
|
0 |
|
EPS Est Next Year
|
0 |
|
Book Value (p.s.)
|
5.92 |
|
Profit Margin (%)
|
-203.3 |
|
Operating Margin (%)
|
-115.2 |
|
Return on Assets (ttm)
|
-14.2 |
|
Return on Equity (ttm)
|
-83.5 |
|
Qtrly Rev. Growth
|
-54.3 |
|
Gross Profit (p.s.)
|
-1.77 |
|
Sales Per Share
|
3.44 |
|
EBITDA (p.s.)
|
-3.14 |
|
Qtrly Earnings Growth
|
0 |
|
Operating Cash Flow
|
-48 (M) |
|
Levered Free Cash Flow
|
185 (M) |
Stock Valuations |
|
PE Ratio
|
-0.07 |
|
PEG Ratio
|
0 |
|
Price to Book value
|
0.21 |
|
Price to Sales
|
0.37 |
|
Price to Cash Flow
|
-1.16 |
Stock Dividends |
|
Dividend
|
0 |
|
Forward Dividend
|
0 |
|
Dividend Yield
|
0% |
|
Dividend Pay Date
|
2020-12-22 |
|
Ex-Dividend Date
|
Invalid DateTime. |
|
Your Ad Here
|
|
